ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery) — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(1 site)
United States
University of Maryland St. Joseph Medical Center, Towson, Maryland Age range
18 Years and older
Last updated December 2025